DocDollars

Exelixis Inc.

CA · United States · Reporting entity ID 100000010545

Total reported 2019–2025
$182.1M
#62 of 2,960 reporting companies — 0.2% of all reported industry payments
$26.5M in general payments across 56,524 records, plus $154.9M in research funding across 29,197 records.

How it breaks down

General payments $26,494,781
Research funding $154,876,332
Ownership & investment $764,109

Where this comes from

Figures are from the CMS Open Payments “payments grouped by reporting entity” dataset, queried live. Reporting entities are applicable manufacturers and group purchasing organisations required to report under the Sunshine Act.

Summary

Exelixis Inc. reported $182.1M to US doctors and teaching hospitals from 2019 to 2025, ranking #62 of 2,960 reporting companies. 85% of that was research funding and 15% general payments such as consulting, speaking, food and travel. 56,524 general payment records and 29,197 research records were filed.

Common questions about Exelixis Inc.

How much has Exelixis Inc. paid US doctors?

Exelixis Inc. reported $182,135,222 to US physicians and teaching hospitals across the 2019–2025 Open Payments program years: $26,494,781 in general payments, $154,876,332 in research funding and $764,109 in ownership and investment interests.

How does Exelixis Inc. rank among drug and device companies?

It ranks #62 of 2,960 reporting entities by total reported value, about 0.2% of all industry payments in the dataset.

Does a payment from Exelixis Inc. mean a doctor did something wrong?

No. Open Payments records transfers of value such as speaking fees, consulting, meals, travel and research funding. The data shows the relationship, not its effect on prescribing or care.